Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway
International Journal of Molecular Sciences · 03.01.2023 · 24 (1) · 858
DOI: 10.3390/ijms24010858 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.01.2023. Verfasst von Wanqiu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Canagliflozin, Diabetic Cardiomyopathies, Ferroptosis, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University.
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is a myocardial disease independent of other cardiovascular diseases, such as coronary heart disease, hypertension, etc. Lipotoxicity is closely related to DCM. In this study, we investigated the mechanism of lipid metabolism disturbance in DCM in HL-1 cells. Through bioinformatics and Western blotting analysis, we found that canagliflozin (CAN) significantly inhibited the expression of inflammatory factors cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). Ferroptosis is mediated by lipid peroxidation. We demonstrated the presence of ferroptosis in cardiomyocytes by detecting intracellular Fe2+ content and the levels of reactive oxygen species (ROS), malondialdehyde (MDA), reduced glutathione (GSH), and mitochondrial membrane potential (MMP). CAN could significantly regulate the indicators of ferroptosis. By using specific inhibitors celecoxib (coxib), S-methylisothiourea sulfate (SMT), Ferrostatin-1 (Fer-1), and Compound C, we further found that CAN regulated inflammation and ferroptosis through AMP-activated protein (AMPK), and inflammation interacted with ferroptosis. Our study indicated that CAN attenuated lipotoxicity in cardiomyocytes by regulating inflammation and ferroptosis through activating the AMPK pathway. This study provides a new direction of myocardial lipotoxicity and some new information for the treatment of DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Key Laboratory in Health Science and Technology, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Open FIESTA Center, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
ORCID-Profile: Wanqiu Zhang, Yaou Zhang, Weidong Xie
Förderung
- Shenzhen Science and Technology Program
- State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University
Zitieren
APA
Zhang, W., Lu, J., Wang, Y., Sun, P., Gao, T., Xu, N., Zhang, Y., & Xie, W. (2023). Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway. International Journal of Molecular Sciences, 24(1), 858. https://doi.org/10.3390/ijms24010858
Vancouver
Zhang W, Lu J, Wang Y, Sun P, Gao T, Xu N, et al. Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway. International Journal of Molecular Sciences. 2023;24(1):858. doi:10.3390/ijms24010858
BibTeX
@article{Zhang2023,
author = {Zhang, Wanqiu and Lu, Jinghua and Wang, Yangyang and Sun, Pengbo and Gao, Tong and Xu, Naihan and Zhang, Yaou and Xie, Weidong},
title = {Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {1},
pages = {858},
doi = {10.3390/ijms24010858}
}
EUVIMED